DOI QR코드

DOI QR Code

인천지역 반려견 유래 세균의 항생제 내성 모니터링 조사

A monitoring survey on antimicrobial resistance of bacterial isolates from companion dogs in Incheon

  • 김경미 (인천광역시보건환경연구원) ;
  • 조민행 (인천광역시보건환경연구원) ;
  • 이승환 (인천광역시보건환경연구원) ;
  • 김경호 (인천광역시보건환경연구원) ;
  • 이정구 (인천광역시보건환경연구원) ;
  • 이성모 (인천광역시보건환경연구원)
  • Kim, Kyung-Mi (Health & Environment Research Institute of Incheon) ;
  • Cho, Min-Haneng (Health & Environment Research Institute of Incheon) ;
  • Lee, Seung-Hwan (Health & Environment Research Institute of Incheon) ;
  • Kim, Kyung-Ho (Health & Environment Research Institute of Incheon) ;
  • Lee, Jung-Gu (Health & Environment Research Institute of Incheon) ;
  • Lee, Sung-Mo (Health & Environment Research Institute of Incheon)
  • 투고 : 2018.12.12
  • 심사 : 2019.03.31
  • 발행 : 2019.06.30

초록

This study was performed to investigate antimicrobial resistance in bacterial isolates obtained from companion dogs in veterinary hospitals and an animal shelter in Incheon. Drug resistance was examined respectively with the isolates of Escherichia coli, Enterococcus faecalis, and Staphylococcus pseudintermedius. The prevalence of drug resistance was calculated for each bacterial species towards 163 E. coli isolates, 156 E. faecalis isolates, and 86 S. pseudintermedius isolates by using selected antimicrobials. E. coli isolates were highly resistant to ampicillin, ciprofloxacin and tetracycline (47.9%, 28.2% and 28.2%, respectively). E. faecalis isolates were highly resistant to quinupristin-dalfopristin, tetracycline, kanamycin, rifampicin (69.8%, 66.0%, 53.8% and 51.9%, respectively). Higher levels of resistance were detected for ampicillin, penicillin, tetracycline, erythromycin, trimethoprim/sulfamethoxazole, telithromycin in S. pseudintermedius isolates (83.7%~52.6%, respectively). Occurrence of methicillin-resistant S. pseudintermedius (MRSP) was confirmed by oxacillin disc diffusion method, resulted in 23.3% occurrence among the S. pseudintermedius isolates (20/86 strains). The occurrence ratio of multidrug-resistance in the isolates of E. coli, E. faecalis, and S. pseudintermedius was 34.5%, 56.9%, and 67.9%, respectively. In this study, higher levels of antimicrobial drug resistance were observed in bacterial isolates obtained from dogs in Incheon. A regular monitoring and surveillance program should be implemented to prevent the emergence and spread of the drug-resistant bacteria carried in companion dogs.

키워드

Table 1. Distribution of 405 bacterial isolates in this study

GCOSBX_2019_v42n2_53_t0001.png 이미지

Table 2. Primers used in the current study

GCOSBX_2019_v42n2_53_t0002.png 이미지

Table 3. Antibiotics used in the study

GCOSBX_2019_v42n2_53_t0003.png 이미지

Table 4. Percentages of antimicrobial resistance 405 bacterial isolates from companion animal

GCOSBX_2019_v42n2_53_t0004.png 이미지

Table 5. Percentage of multidrug-resistance in 350 bacterial isolates from companion animal

GCOSBX_2019_v42n2_53_t0005.png 이미지

Table 6. Distribution of methicillin-resistance gene among S. pseudintermedius isolates

GCOSBX_2019_v42n2_53_t0006.png 이미지

참고문헌

  1. 농림축산식품부. 2016. 축산 분야(반려동물포함) 항생제 내성 관리 계획.
  2. 농림축산검역본부. 2017. 2017년 동물보호에 대한 국민 의식 조사.
  3. Bannoehr J, Guardadassi L. 2012. Staphylococcus pseudintermedius in the dog: taxonomy, diagnostics, ecology, epidemiology and pathogenicity. Vet Dermatol 23(4): 253-266. https://doi.org/10.1111/j.1365-3164.2012.01046.x
  4. Caprioli A, Busani L, Martel JL, Hemuth R. 2000. Monitoring of antibiotic resistance in bacteria of animal origin: epidemiological and microbiological methodologies. Int J Antmicrob Agents 14(4): 295-301. https://doi.org/10.1016/S0924-8579(00)00140-0
  5. Carattoli A, Lovari S, Franco A, Cordaro G, Matteo PD, Battisti A. 2005. Extended-Spectrum ${\beta}$-Lactamases in Escherichia coli isolated from Dogs and Cats in Rome, Italy, from 2001 to 2003. Antimicrob Agents Chemother 49(2): 833-835. https://doi.org/10.1128/AAC.49.2.833-835.2005
  6. Cho JK, Lee MR, Kim JM, Kim HD, 2016. Methicillin-resistant or susceptible staphylococcus pseudintermedius isolates from dogs and cats. Korean J Vet serv 39(3): 175-181. https://doi.org/10.7853/KJVS.2016.39.3.175
  7. Clinical and Laboratory Standards Institute(CLSI). 2017. Performance standards for antimicrobial susceptibility testing, Twenty-seven informational supplement, CLSI document M100-S27.
  8. Cosgrove SE. 2006. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 42(2): 82-89. https://doi.org/10.1086/498512
  9. Devriese LA, Vancanneyt M, Baele M, De Graef E, Snauwaert C, Cleenwerck I, Dawyndt P, Swings J, Decostere A, Haesebrouck F. 2005. Staphylococcus pseudintermedisus sp. nov., a coagulase-positive species from animals. Int J Syst Evol Microbiol 55(4): 1569-1573. https://doi.org/10.1099/ijs.0.63413-0
  10. Dziva F, Wint C, Auguste T, Heeraman C, Dacon C, Yu P, Koma LM. 2015. First identification of methicillin-resistant Staphylococcus pseudintermedius strains among coagulase-positive staphylococci isolated from dogs with otitis externa in Trinidad, West Indies. Infect Ecol Epidemiol 5(1): 29170 http://doi.org/10.3402/iee.v5.29170.
  11. Kang DJ, Chung B.H, Heo J, Kang CB. 2009. Study on Companion Dog Practice and Management System on Animal Hospital in Seoul city. J Agri Life Sci 43(2): 39-46.
  12. Kang MH, Chae MJ, Yoo JW, Kim SG, Lee SY, Yoo JH, Park HM. 2014. Antibiotic resistance and molecular characterization of ophthalmic Staphylococcus pseudintermedius isolates from dogs. J Vet Sci 15(3): 409-415. https://doi.org/10.4142/jvs.2014.15.3.409
  13. Kloos WE. 1980. Natural populations of the genus Staphylococcus. Annu Rev Microbiol 34: 559-592. https://doi.org/10.1146/annurev.mi.34.100180.003015
  14. Kwon KH, Hwang SY, Moon BY, Park YK, Shin S, Hwang CY, Park YH. 2012. Occurrence of antimicrobial resistance and virulence genes, and distribution of enterococcal clonal complex 17 from animals and human beings in Korea. J Vet Diagn Invest 24(5): 924-931. https://doi.org/10.1177/1040638712455634
  15. Lee DK, Kim Y, Park KS, Yang JW, Kim K, Ha NJ. 2007. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin /dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005). J Biochem Mol Biol 40(6): 881-887.
  16. Loeffler A, Linek M, Moodley A, Guardabassi L, Sung JM, Winkler M, Weiss R, Lloyd DH. 2007. First report of multiresistant, mecA-positive Staphylococcus intermedius in Europe: 12 cases from a veterinary dermatology referral clinic in Germany. Vet Dermatol 18(6): 412-421. https://doi.org/10.1111/j.1365-3164.2007.00635.x
  17. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbath S, Hindler JF, Kahlmeter G, Olsson-Liljeuist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3): 268-281. https://doi.org/10.1111/j.1469-0691.2011.03570.x
  18. Miller k, O'Neill AJ, Chopra I. 2004. Escherichia coli Mutators Present an Enhanced Risk for Emergence of Antibiotic Resistance during Urinary Tract Infections. Antimicrob Agents Chemother 48(1): 23-29. https://doi.org/10.1128/AAC.48.1.23-29.2004
  19. Murray BE. 1998. Diversity among multidrug-resistant enterococci. Emerg Infect Dis 4(1): 37-47. https://doi.org/10.3201/eid0401.980106
  20. Nam HM, Lee HS, Byun JW, Yoon SS, Jung SC, Joo YS, Lim SK. 2010. Prevalence of antimicrobial resistance in fecal Escherichia coli isolates from stray pet dogs and hospitalized pet dogs in korea. Microb Drug Resist 16(1): 75-79. https://doi.org/10.1089/mdr.2009.0125
  21. Oh YI, Kim HJ, Kim YM, Kim SS, Kim JK, Kim HW, Kang BJ, Youn HY. 2017. Antimicrobial Resistance of Bacterial Isolates from Positive Urine Culture in Four Hundred Five Dogs Between 2013-2014. Intern J Appl Res Vet Med 15(2): 99-107.
  22. Pitout JD, Laupland KB. 2008. Extended-spectrum ${\beta}$-lactamase - producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8(3): 159-166. https://doi.org/10.1016/S1473-3099(08)70041-0
  23. Platell JL, Cobbold RN, Johnson JR, Trott DJ. 2010. Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia. J Antimicrob Chemother 65(9): 1936-1938. https://doi.org/10.1093/jac/dkq236
  24. Sava IG, Heikens E, Huebner J. 2010. Pathogenesis and immunity in enterococcal infections. Clin Microbiol Infect 16(6): 533-540. https://doi.org/10.1111/j.1469-0691.2010.03213.x
  25. So JH, Kim J, Bae IK, Jeong SH, Kim SH, Lim SK, Park YH, Lee K. 2012. Dissemination of multidrug-resistant Escherichia coli in Korean veterinary hospitals. Diagn Microbiol Infect Dis 73(2): 195-199. https://doi.org/10.1016/j.diagmicrobio.2012.03.010
  26. Talan DA, Staatz D, Staatz A, Goldstein EJ, Singer K, Overturf GD. 1989. Staphylococcus intermedius in canine gingiva and canine-inflicted human wound infections: laboratory characterization of a newly recognized zoonotic pathogen. J Clin Microbiol 27(1): 78-81. https://doi.org/10.1128/JCM.27.1.78-81.1989
  27. Tuerena I, Willimas NJ, Nuttall T, Pinchbeck G. 2016. Antimicrobial-resistant Escherichia coli in hospitalised companion animals and their hospital environment. J Small Anim Pract 57(7): 339-347. https://doi.org/10.1111/jsap.12525
  28. van Duijkeren E, Catry B, Greko C, Moreno MA. 2011. Review on methicillin-resistant Staphylococcus pseudintermedius. J Antimicrob Chemother 66(12): 2705-2714. https://doi.org/10.1093/jac/dkr367
  29. Weese JS. 2008. Issues regarding the use of vancomycin in companion animals. J Am Vet Med Assoc 233(4): 565-567. https://doi.org/10.2460/javma.233.4.565
  30. Weese JS, van Duijkeren E. 2010. Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius in veterinary medicine. Vet Microbiol 140(3-4): 418-429. https://doi.org/10.1016/j.vetmic.2009.01.039
  31. Yazgi H, Ertek M, Erol S, Ayyildiz A. 2002. A comparison of high-level aminoglycoside resistance in vancomycin-sensitive and vancomycin-resistant Enterococcus species. J Int Med Res 30(5): 529-534. https://doi.org/10.1177/147323000203000510
  32. Yoo JH, Yoon J.W, Lee SY, Park HM. 2010. High prevalence of Fluoroquinolone-and Methicillin-resistant Staphylococcus pseudintermedius isolates from canine pyoderma and otitis externa in veterinary teaching hospital. J Microbiol Biotechnol. 20(4): 798-802. https://doi.org/10.4014/jmb.0910.10044
  33. Yoon JW, Lee KJ, Lee SY, Chae MJ, Park JK, Yoo JH, Park HM. 2010. Antibiotic resistance profiles of Staphylococcus pseudintermedius isolates from canine patients in Korea. J Microbiol Biotechnol. 20(12): 1764-1768. https://doi.org/10.4014/jmb.1001.01011
  34. Yoon YK, Sim HS, Kim JY, Park DW, Sohn JW, Roh KH, Lee SE, Kim MJ. 2009. Epidemiology and control of an outbreak of vancomycin-resistant enterococci in the intensive care units. Yonsei Med J 50(5): 637-643. https://doi.org/10.3349/ymj.2009.50.5.637
  35. Zubeir IE, Kanbar T, Alber J, Lammler C, Akineden O, Weiss R, Zschock M. 2007. Phenotypic and genotypic characteristics of methicillin/oxacillin-resistant Staphylococcus intermedius isolated from clinical specimens during routine veterinary microbiological examinations. Vet Microbiol 12l(1-2): 170-176.

피인용 문헌

  1. 태안군 이원면 육상오염원 배출수에서 분리한 그람음성균의 항생제 내성 특성 vol.54, pp.4, 2019, https://doi.org/10.5657/kfas.2021.0377